Celebrex Study halted because of more than twice as many heart attacks as placebo

The U.S. Food and Drug Administration released a study in November 2004 that said VIOXX may have contributed to an additional 27,785 heart attacks or deaths from 1999 to 2003.

A new analysis published online by the British journal The Lancet could help fuel the lawsuits. (Read ‘Celebrex Study halted.’…)